Authors:
Du, XL
Suguro, M
Hirabayashi, K
Mori, A
Nishikata, T
Hagiwara, N
Kawata, K
Okeda, T
Wang, HF
Fugami, K
Kosugi, M
Citation: Xl. Du et al., Mizoroki-heck type reaction of organoboron reagents with alkenes and alkynes. A Pd(II)-catalyzed pathway with Cu(OAc)(2) as an oxidant, ORG LETT, 3(21), 2001, pp. 3313-3316
Authors:
Yonemori, K
Kanda, Y
Yamamoto, R
Hamaki, T
Suguro, M
Chizuka, A
Matsuyama, T
Takezako, N
Miwa, A
Togawa, A
Citation: K. Yonemori et al., Clinical value of serial measurement of serum C-reactive protein level in neutropenic patients, LEUK LYMPH, 41(5-6), 2001, pp. 607-614
Authors:
Kanda, Y
Arai, C
Chizuka, A
Yamamoto, R
Hamaki, T
Suguro, M
Matsuyama, T
Takezako, N
Miwa, A
Tohma, J
Shirakawa, K
Yatomi, T
Nakamura, N
Hirai, H
Togawa, A
Citation: Y. Kanda et al., Lack of correlation between clinical characteristics and serum soluble Fasligand levels in patients with multiple myeloma, LEUK LYMPH, 40(3-4), 2001, pp. 351-356
Citation: A. Mori et M. Suguro, Silicone as a new class of organosilicon reagent for the palladium-catalyzed cross-coupling reaction, SYNLETT, (6), 2001, pp. 845-847
Authors:
Oshima, K
Kanda, Y
Nannya, Y
Kaneko, M
Hamaki, T
Suguro, M
Yamamoto, R
Chizuka, A
Matsuyama, T
Takezako, N
Miwa, A
Togawa, A
Niino, H
Nasu, M
Saito, K
Morita, T
Citation: K. Oshima et al., Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma, AM J HEMAT, 67(1), 2001, pp. 1-5
Authors:
Mori, A
Kawashima, J
Shimada, T
Suguro, M
Hirabayashi, K
Nishihara, Y
Citation: A. Mori et al., Non-Sonogashira-type palladium-catalyzed coupling reactions of terminal alkynes assisted by silver(I) oxide or tetrabutylammonium fluoride, ORG LETT, 2(19), 2000, pp. 2935-2937
Authors:
Kanda, Y
Yamamoto, R
Chizuka, A
Suguro, M
Hamaki, T
Matsuyama, T
Takezako, N
Miwa, A
Togawa, A
Kume, M
Tsukuda, M
Hasuo, K
Citation: Y. Kanda et al., Treatment of deep vein thrombosis using temporary vena caval filters afterallogeneic bone marrow transplantation, LEUK LYMPH, 38(3-4), 2000, pp. 429-433
Authors:
Kanda, Y
Arai, C
Chizuka, A
Suguro, M
Hamaki, T
Yamamoto, R
Yamauchi, Y
Matsuyama, T
Takezako, N
Shirai, Y
Miwa, A
Iwasaki, K
Nasu, M
Togawa, A
Citation: Y. Kanda et al., Pyogenic granuloma of the tongue early after allogeneic bone marrow transplantation for multiple myeloma, LEUK LYMPH, 37(3-4), 2000, pp. 445-449
Authors:
Kono, N
Kanda, Y
Yamamoto, R
Chizuka, A
Suguro, M
Hamaki, T
Arai, C
Matsuyama, T
Takezako, N
Miwa, A
Togawa, A
Citation: N. Kono et al., Prognostic significance of serum soluble interleukin-2 receptor level in Non-Hodgkin's lymphoma: A single center study in Japan, LEUK LYMPH, 37(1-2), 2000, pp. 151-156
Authors:
Suguro, M
Kanda, Y
Yamamoto, R
Chizuka, A
Hamaki, T
Matsuyama, T
Takezako, N
Miwa, A
Togawa, A
Citation: M. Suguro et al., High serum lactate dehydrogenase level predicts short survival after vincristine-doxorubicin-dexamethasone (VAD) salvage for refractory multiple myeloma, AM J HEMAT, 65(2), 2000, pp. 132-135
Authors:
Yamamoto, R
Kanda, Y
Matsuyama, T
Oshima, K
Nannya, Y
Suguro, M
Chizuka, A
Hamaki, T
Takezako, N
Miwa, A
Kami, M
Mori, S
Kojima, T
Saito, K
Itaoka, Y
Kashida, M
Citation: R. Yamamoto et al., Myopericarditis caused by cyclophosphamide used to mobilize peripheral blood stem cells in a myeloma patient with renal failure, BONE MAR TR, 26(6), 2000, pp. 685-688
Authors:
Hirabayashi, E
Mori, A
Kawashima, J
Suguro, M
Nishihara, Y
Hiyama, T
Citation: E. Hirabayashi et al., Palladium-catalyzed cross-coupling of silanols, silanediols, and silanetriols promoted by silver(I) oxide, J ORG CHEM, 65(17), 2000, pp. 5342-5349
Authors:
Kanda, Y
Yamamoto, R
Chizuka, A
Hamaki, T
Suguro, M
Arai, C
Matsuyama, T
Takezako, N
Miwa, A
Kern, W
Kami, M
Akiyama, H
Hirai, H
Togawa, A
Citation: Y. Kanda et al., Prophylactic action of oral fluconazole against fungal infection in neutropenic patients - A meta-analysis of 16 randomized, controlled trials, CANCER, 89(7), 2000, pp. 1611-1625
Authors:
Kanda, Y
Hamaki, T
Yamamoto, R
Chizuka, A
Suguro, M
Matsuyama, T
Takezako, N
Miwa, A
Kami, M
Hirai, H
Togawa, A
Citation: Y. Kanda et al., The clinical significance of CD34 expression in response to therapy of patients with acute myeloid leukemia - An overview of 2483 patients from 22 studies, CANCER, 88(11), 2000, pp. 2529-2533